TUBGCP4 | Tubulin, gamma complex associated protein 4 | | | | | | Expressed in all |
TP53BP1 | Tumor protein p53 binding protein 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MAP1A | Microtubule-associated protein 1A | FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
PPIP5K1 | Diphosphoinositol pentakisphosphate kinase 1 | Enzymes
| | | | | Expressed in all |
PDIA3 | Protein disulfide isomerase family A, member 3 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ELL3 | Elongation factor RNA polymerase II-like 3 | | | | | | Tissue enhanced |
WDR76 | WD repeat domain 76 | | | | | | Mixed |
CASC4 | Cancer susceptibility candidate 4 | | | | | | Expressed in all |
EIF3J | Eukaryotic translation initiation factor 3, subunit J | Plasma proteins
| | | | | Expressed in all |
SPG11 | Spastic paraplegia 11 (autosomal recessive) | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
TRIM69 | Tripartite motif containing 69 | | | | | | Expressed in all |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins
| | | | | Group enriched |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
C15orf48 | Chromosome 15 open reading frame 48 | | | | | | Tissue enhanced |
BLOC1S6 | Biogenesis of lysosomal organelles complex-1, subunit 6, pallidin | Disease related genes
| | | | | Expressed in all |
SQRDL | Sulfide quinone reductase-like (yeast) | Mitochondrial proteins
| | | | | Expressed in all |
MYEF2 | Myelin expression factor 2 | | | | | | Mixed |
CTXN2 | Cortexin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
DUT | Deoxyuridine triphosphatase | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
FBN1 | Fibrillin 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CEP152 | Centrosomal protein 152kDa | Disease related genes Plasma proteins
| | | | | Mixed |
EID1 | EP300 interacting inhibitor of differentiation 1 | | | | | | Expressed in all |
COPS2 | COP9 signalosome subunit 2 | | | | | | Expressed in all |
GALK2 | Galactokinase 2 | Enzymes
| | | | | Expressed in all |
SLC27A2 | Solute carrier family 27 (fatty acid transporter), member 2 | Enzymes Predicted membrane proteins Transporters
| | | | | Group enriched |
GABPB1 | GA binding protein transcription factor, beta subunit 1 | | | | | | Expressed in all |
USP8 | Ubiquitin specific peptidase 8 | Enzymes
| | | | | Expressed in all |
SPPL2A | Signal peptide peptidase like 2A | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CYP19A1 | Cytochrome P450, family 19, subfamily A, polypeptide 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GLDN | Gliomedin | | | | | | Tissue enhanced |
SCG3 | Secretogranin III | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
LYSMD2 | LysM, putative peptidoglycan-binding, domain containing 2 | | | | | | Expressed in all |
TMOD3 | Tropomodulin 3 (ubiquitous) | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
LEO1 | Leo1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | | | | | | Expressed in all |
MAPK6 | Mitogen-activated protein kinase 6 | Enzymes
| | | | | Expressed in all |
BCL2L10 | BCL2-like 10 (apoptosis facilitator) | Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MYO5C | Myosin VC | | | | | | Expressed in all |
MYO5A | Myosin VA (heavy chain 12, myoxin) | Disease related genes Plasma proteins
| | | | | Expressed in all |
RSL24D1 | Ribosomal L24 domain containing 1 | Ribosomal proteins
| | | | | Expressed in all |
RAB27A | RAB27A, member RAS oncogene family | Disease related genes
| | | | | Expressed in all |
DYX1C1 | Dyslexia susceptibility 1 candidate 1 | Disease related genes
| | | | | Tissue enhanced |
PRTG | Protogenin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RFX7 | Regulatory factor X, 7 | Transcription factors
| | | | | Expressed in all |
MNS1 | Meiosis-specific nuclear structural 1 | | | | | | Group enriched |
ZNF280D | Zinc finger protein 280D | Transcription factors
| | | | | Expressed in all |
CGNL1 | Cingulin-like 1 | Disease related genes
| | | | | Tissue enhanced |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FAM63B | Family with sequence similarity 63, member B | | | | | | Expressed in all |